Your address will show here +12 34 56 78
PHOENIX, Aug. 14, 2019 (GLOBE NEWSWIRE) — Item 9 Labs Corp. (INLB) (“Item 9 Labs” or the “Company”), a leader in comfortable cannabis health solutions for the modern consumer, today announced the launch of its new product suite, “Cocktails,” a unique first to market disposable vape pen with cartridge and battery inspired by popular culture’s classic aperitifs.
The Item 9 Labs mixology team developed the craft-cannabis line utilizing organic fruit, botanically-derived terpenes, and 100 percent solvent-free distillate. The long-lasting disposable Cocktails vape pen is supplemented by a charging port for those patients who medicate less frequently. Cocktails comes with 300 mg. of premium distillate in four signature flavors including Blackberry Mojito, Piña Colada, Old Fashioned, and Strawberry Daiquiri.
With eye popping premium packaging and a minimalist sleek design, the Cocktails vape pen features a robust 280mAH breath-activated battery that lasts for approximately 300 inhales between recharges, offering cannabis patients a discreet, portable, and easy way to medicate.
The Company hosted an official brand kick-off event in Phoenix on July 26th. Nearly three hundred cannabis industry professionals attended the private event, where budtenders, buyers, and management from ten area dispensaries enjoyed a custom curated menu and themed cocktails celebrating the new product.
“The Cocktails brand embodies the company mantra ‘in good times.’ It’s a fresh approach to the growing wellness trend of alcohol-free bars coupled with the rise in vape product consumption,” stated Vice President of Marketing, Kyle Jennings.
According to Arcview Market Research, U.S. concentrate product sales are estimated to reach $8.4 billion by 2022, with vaping as the primary modality.
Headquartered in Phoenix, Item 9 Labs has received multiple accolades for its medical-grade flower and concentrates. Most recently, the Company’s Candyland and Tres Leches cannabis flower strains were named 1st Place Sativa and 2nd Place Hybrid respectively at Arizona’s 2019 Errl Cup Awards.
Item 9 Labs is bringing dynamic product suites and progressive new delivery platforms to the industry. Cocktails is available at select Arizona dispensaries, for more information visit Item9LabsCorp.com.

To read the full article, click here by Neko Catanzaro.

Source: GlobeNewsWire via QuoteMedia

0

PHOENIX, July 22, 2019 (GLOBE NEWSWIRE) — Item 9 Labs Corp. (OTC: INLB) (“Item 9 Labs” or the “Company”), a leader in comfortable cannabis health solutions for the modern consumer, today announced the launch of its new corporate site and brand image. The logo and style updates strengthen the Company’s national market share positioning under one unified identity.

“Item 9 Labs has expanded significantly in the past year and it was important for us to reshape our corporate branding to reflect this evolution. Our new identity echoes our dynamic and innovative  attributes that have set us apart in a highly competitive market,” stated CEO Sara Gullickson.

In November 2018, Item 9 Labs acquired the assets of Arizona DP Consulting, LLC, which included the international cannabis consulting firm Dispensary Permits, digital technology platform DispensaryTemplates.com, and Strive Life, a turnkey dispensary model for the retail sector. In addition, Item 9 Labs has secured partnerships with distribution and processing operation Strive Wellness of Nevada and dispensary Strive Life North Dakota.

“We now have more than five brands and multiple assets under our umbrella, so it was natural for our visual narrative to evolve and integrate the Company as a whole,” commented Vice President of Marketing Kyle Jennings. “We have tied together all of the corporate entities to operate as one unit in sync with each other.”

The brand transition includes new Company websites and an upgraded logo, showcasing a sleek and minimalist design approach. This bold, modern style echoes a continued commitment to quality, innovation, and diversity and visually ushers in a new era of strategic growth and advancement at Item 9 Labs.

Headquartered in Phoenix, Item 9 Labs is bringing best industry practices to markets from coast to coast through cultivation, dispensary, and processing operations, as well as licensing services, and medical cannabis product suites. The Company intends to manage facilities in six to ten U.S. cannabis markets by the end of 2019.

 

For information visit Item9LabsCorp.com.

 

To read the full article, click here by Neko Catanzaro.

Source: GlobeNewsWire via QuoteMedia

0

PHOENIX, July 02, 2019 (GLOBE NEWSWIRE) — Item 9 Labs Corp. (OTC: INLB) (“Item 9 Labs” or the “Company”), a leader in comfortable cannabis health solutions for the modern consumer, announced the filing of a Form 10 with the U.S. Securities and Exchange Commission (“SEC”). The filing provides investor detailed information on Item 9 Labs business, operations, overview of business strategy, risk factors and audited financial results.

Following the effective date of the Form 10, the Company will be subject to the reporting requirements of the Exchange Act of 1934, as amended, including requirements to begin filing reports on Form 10-K, Form 10-Q, and Form 8-K and subjects itself to additional reporting obligations related to proxies, shareholder actions and stock ownership rules.

“Filing the Form 10 is a significant milestone for the Company, adding value, liquidity and transparency for our shareholders. Becoming a fully reporting public company is a milestone that sets the stage for our commitment to our growth strategy and we are grateful for our shareholders continued support,” stated Bobby Mikkelsen, CFO at Item 9 Labs.

A copy of the filing is available on the SEC’s website at www.sec.gov under the name Item 9 Labs Corp.

 

To read the full article, click here by Neko Catanzaro.

Source: GlobeNewsWire via QuoteMedia

0

Appoints Kyle Jennings as Vice President and outside consulting Creative Director

SCOTTSDALE, Ariz., June 28, 2019 (GLOBE NEWSWIRE) — Item 9 Labs Corp. (OTC: INLB) (Item 9 Labs or the Company), a leader in comfortable cannabis health solutions for the modern consumer, today announced the expansion of its corporate marketing team with the appointment of Kyle Jennings as Vice President and the hiring of RC Giant LLC, as consulting Creative Director.

“As Item 9 Labs grows, it was important for us to build a team with cannabis and mainstream marketing expertise. Our new additions have a strong track record managing high-level campaigns for global brands and we are excited to have them on board,” stated Sara Gullickson, CEO of Item 9 Labs.

Jennings previously served as Director of Brand Development at Sunday Goods where he managed licensed cannabis products Apothecanna and Mr. Moxey’s Mints as well as marketing programs in Arizona and California.

Prior to entering the cannabis space, Jennings lead sales initiatives for mainstream sports and wellness brands, including Red Bull, 5-hour ENERGY, KIND healthy snacks, NASCAR, the National Hockey League, and Major League Baseball. While at Red Bull, Jennings managed a team of 30 people and marketing channels in Arizona, Nevada, and New Mexico,  driving the sales of three million cases annually.

“I am extremely excited to join such an incredible team and brand.  The internal culture, vision, and passion at Item 9 Labs is second to none.  The daily love that goes into our amazing products and our patient first mentality has set us up to do great things,” stated Jennings.

The Company’s consulting Creative Director, RC Giant, brings over 20 years of creative design, product placement, product development, and big box retail expertise to Item 9 Labs. RC Giant’s team brings expertise such as former Art Director at Action Sports Management, one of the first extreme sports management agencies owned by professional motocross and skateboard athletes, and owner of a sports design agency which has directed local and national campaigns and developed products with China-based factories.

Item 9 Labs is an all-encompassing cannabis enterprise with diverse product suites and medical cannabis operations in multiple U.S. markets. Current facilities include distribution and processing operation Strive Wellness of Nevada and dispensary Strive Life Grand Forks in North Dakota. Item 9 Labs is also an operational partner of distribution and processing facility Strive Wellness of Ohio.

For information visit Item9LabsCorp.com.

 

To read the full article, click here by Neko Catanzaro.

Source: GlobeNewsWire via QuoteMedia

0

Newly Expanded Arizona Cultivation Facility to Begin Production This Week

PHOENIX, June 11, 2019 (GLOBE NEWSWIRE) — Item 9 Labs Corp. (OTC: INLB) (“Item 9 Labs” or the “Company”), a leader in comfortable cannabis health solutions for the modern consumer, today announced its expanded Arizona cultivation and manufacturing facility has received state approval to operate. The custom 10,000 square-foot construction passed inspections on June 4th and will begin production this week.

Several years of research and development went into analyzing the Company’s original cultivation site before expansion commenced in 2018. The new building features technology improvements in all areas of the grow process, including advanced irrigation, lighting, HVAC, and upgraded environmental controls.

“Our expanded Arizona facility will enable us to increase our cultivation and extraction production by approximately 150 percent, while maintaining a weekly harvest schedule,” stated Item 9 Labs CEO Sara Gullickson.

The Item 9 Labs Arizona facility now totals 20,000 square-feet consisting of 8 flower rooms, just over 1,000 square-feet of nursery space, an Extraction Laboratory, and an Infusion Kitchen for increased manufacturing capabilities.

“The completion of this project is a significant milestone for the organization,” commented COO Chris Wolven. “We were able to build our dream facility from the ground up, allowing us to expand on our award-winning quality products, grow our revenue, and onboard new talent.”

The improvements complete the second-phase of a three-tiered development initiative and continues Item 9 Labs’ strategic growth plan. The Company will hire approximately 20 new individuals to its operations force, as well as build its marketing, design, sales, and training teams.

Headquartered in Southern Arizona, Item 9 Labs is renowned for its award-winning flower, diverse concentrate products, and proprietary THC and CBD-derived delivery systems, including an Intra-Nasal device and Apollo Vape Pen and Pod System. The Company intends to manage cultivation, processing, distribution, and dispensary facilities in six to ten U.S. cannabis markets by the end of 2019.

 

To read the full article, click here by Neko Catanzaro.

Source: GlobeNewsWire via QuoteMedia

0